Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Evaluation of the combined use of two different respiratory monitoring systems for 4D CT simulation and gated treatment.

Liu J, Lin T, Fan J, Chen L, Price R, Ma CC.

J Appl Clin Med Phys. 2018 Sep;19(5):666-675. doi: 10.1002/acm2.12434. Epub 2018 Aug 13.

2.

Local Control and Toxicity of External Beam Reirradiation With a Pulsed Low-dose-rate Technique.

Lee CT, Dong Y, Li T, Freedman S, Anaokar J, Galloway TJ, Hallman MA, Weiss SE, Hayes SB, Price RA, Ma CMC, Meyer JE.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):959-964. doi: 10.1016/j.ijrobp.2017.12.012. Epub 2017 Dec 23.

PMID:
29485075
3.

When and how to treat an IMRT patient on a second accelerator without replanning?

Lin T, Hossain M, Fan J, Ma CC.

Med Dosim. 2018 Winter;43(4):334-343. doi: 10.1016/j.meddos.2017.11.003. Epub 2017 Dec 26.

PMID:
29287919
4.

Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial.

Huang JF, Zhang FZ, Zou QZ, Zhou LY, Yang B, Chu JJ, Yu JH, Zhang HW, Yuan XP, Tai GM, Liu FJ, Ma CC.

Oncotarget. 2017 Jan 10;8(2):2457-2465. doi: 10.18632/oncotarget.13899.

5.

Investigation of the clinical potential of scattering foil free electron beams.

Eldib A, Jin L, Li J, Ma CM.

Phys Med Biol. 2014 Feb 21;59(4):819-36. doi: 10.1088/0031-9155/59/4/819. Epub 2014 Feb 3.

PMID:
24487461
6.

Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.

Ren JH, Dai XF, Yan GL, Jin M, Liu CW, Yang KY, Wu G, Ma CM.

Int J Radiat Biol. 2014 Mar;90(3):256-61. doi: 10.3109/09553002.2014.873558. Epub 2014 Jan 24.

PMID:
24350917
7.

Feasibility of replacing patient specific cutouts with a computer-controlled electron multileaf collimator.

Eldib A, Jin L, Li J, Ma CM.

Phys Med Biol. 2013 Aug 21;58(16):5653-72. doi: 10.1088/0031-9155/58/16/5653. Epub 2013 Jul 29.

PMID:
23892910
8.

Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.

Dai XF, Ding J, Zhang RG, Ren JH, Ma CM, Wu G.

Int J Radiat Biol. 2013 Sep;89(9):724-31. doi: 10.3109/09553002.2013.791405. Epub 2013 May 31.

PMID:
23682582
9.

Target repositional accuracy and PTV margin verification using three-dimensional cone-beam computed tomography (CBCT) in stereotactic body radiotherapy (SBRT) of lung cancers.

Wang L, Feigenberg S, Fan J, Jin L, Turaka A, Chen L, Ma CM.

J Appl Clin Med Phys. 2012 Mar 8;13(2):3708. doi: 10.1120/jacmp.v13i2.3708.

10.

Point/counterpoint: pulsed reduced dose rate radiation therapy is likely to become the treatment modality of choice for recurrent cancers.

Ma CM, Luxton G, Orton CG.

Med Phys. 2011 Sep;38(9):4909-11. doi: 10.1118/1.3583794. No abstract available.

PMID:
21978035
11.
12.

Rectal dose variation during the course of image-guided radiation therapy of prostate cancer.

Chen L, Paskalev K, Xu X, Zhu J, Wang L, Price RA, Hu W, Feigenberg SJ, Horwitz EM, Pollack A, Ma CM.

Radiother Oncol. 2010 May;95(2):198-202. doi: 10.1016/j.radonc.2010.02.023. Epub 2010 Mar 18.

PMID:
20303193
13.

Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning.

Chetty IJ, Curran B, Cygler JE, DeMarco JJ, Ezzell G, Faddegon BA, Kawrakow I, Keall PJ, Liu H, Ma CM, Rogers DW, Seuntjens J, Sheikh-Bagheri D, Siebers JV.

Med Phys. 2007 Dec;34(12):4818-53. Review.

14.

Magnetic resonance-based treatment planning for prostate intensity-modulated radiotherapy: creation of digitally reconstructed radiographs.

Chen L, Nguyen TB, Jones E, Chen Z, Luo W, Wang L, Price RA Jr, Pollack A, Ma CM.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):903-11.

PMID:
17544002
15.
16.

In-room CT techniques for image-guided radiation therapy.

Ma CM, Paskalev K.

Med Dosim. 2006 Spring;31(1):30-9. Review.

PMID:
16551527
17.

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA Jr.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):518-26. Epub 2005 Oct 19.

18.

MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.

Chen L, Price RA Jr, Wang L, Li J, Qin L, McNeeley S, Ma CM, Freedman GM, Pollack A.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):636-47.

PMID:
15380601
19.

A method for increased dose conformity and segment reduction for SMLC delivered IMRT treatment of the prostate.

Price RA, Murphy S, McNeeley SW, Ma CM, Horwitz E, Movsas B, Raben A, Pollack A.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):843-52.

PMID:
14529792

Supplemental Content

Loading ...
Support Center